MicroRNA is the master regulator of the genome—researchers are learning how to harness the way it controls genes

by Andrea Kasinski,The ConversationMicroRNA can silence genes by binding to mRNA. Credit:Kajsa Mollersen/Wikimedia Commons,CC BY-SAThe Earthformed 4.5 billion years ago, and li

Updated on: December 20,2023

MicroRNA is the master regulator of the genome—researchers are learning how to harness the way it controls genes

by Andrea Kasinski,The ConversationMicroRNA can silence genes by binding to mRNA. Credit:Kajsa Mollersen/Wikimedia Commons,CC BY-SAThe Earthformed 4.5 billion years ago, and li

Updated on:December 20,2023

Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainUpdated toxicity data from the ongoing SWOG/NRG 1806 clinical trial, which tests combining chemoradiation therapy with immunotherapy in

Updated on: December 20,2023

Toxicity data reveal no safety concerns with S/N1806 bladder cancer trial

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainUpdated toxicity data from the ongoing SWOG/NRG 1806 clinical trial, which tests combining chemoradiation therapy with immunotherapy in

Updated on:December 20,2023

New optimism on myelodysplastic syndromes

by Sylvester Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainPhysician scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have publish

Updated on: December 22,2023

New optimism on myelodysplastic syndromes

by Sylvester Comprehensive Cancer CenterCredit: Pixabay/CC0 Public DomainPhysician scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have publish

Updated on:December 22,2023

Multicancer early detection feasible for outpatients

A blood-based multicancer early detection (MCED) test using cell-free DNA (cfDNA) is feasible for outpatients and has a positive predictive value of about 40 percent, according to a study presented at

Updated on: December 21,2023

Multicancer early detection feasible for outpatients

A blood-based multicancer early detection (MCED) test using cell-free DNA (cfDNA) is feasible for outpatients and has a positive predictive value of about 40 percent, according to a study presented at

Updated on:December 21,2023

Blood Stem Cell Mutations Exacerbate Colon Cancer Growth

byColleen Fleisson August 26, 2023Certaincolon cancersmay experience accelerated growth due to typical age-related alterations in the blood system, said University of Florida C

Updated on: December 19,2023

Blood Stem Cell Mutations Exacerbate Colon Cancer Growth

byColleen Fleisson August 26, 2023Certaincolon cancersmay experience accelerated growth due to typical age-related alterations in the blood system, said University of Florida C

Updated on:December 19,2023

New insights into the drivers of glioma-related epilepsy

by Graciela Gutierrez,Baylor College of MedicineGraphical abstract. Credit:Neuron(2023). DOI: 10.1016/j.neuron.2023.01.013Glioma is one of the most aggressive malignant primary brain

Updated on: December 20,2023

New insights into the drivers of glioma-related epilepsy

by Graciela Gutierrez,Baylor College of MedicineGraphical abstract. Credit:Neuron(2023). DOI: 10.1016/j.neuron.2023.01.013Glioma is one of the most aggressive malignant primary brain

Updated on:December 20,2023

Scientists develop new ultrasound technique for earlier detection and diagnosis of breast cancer

byNational Physical LaboratoryCredit: Unsplash/CC0 Public DomainScientists at the UK's National Physical Laboratory (NPL) have demonstrated the first in-person measurements of breast tissue

Updated on: December 27,2023

Scientists develop new ultrasound technique for earlier detection and diagnosis of breast cancer

byNational Physical LaboratoryCredit: Unsplash/CC0 Public DomainScientists at the UK's National Physical Laboratory (NPL) have demonstrated the first in-person measurements of breast tissue

Updated on:December 27,2023

SABCS: Updated analysis confirms endocrine therapy effective with/without chemo

by Elana GotkineFor patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-negative early breast cancer (EBC) with a 21-gene recurrence score (RS)

Updated on: December 17,2023

SABCS: Updated analysis confirms endocrine therapy effective with/without chemo

by Elana GotkineFor patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, node-negative early breast cancer (EBC) with a 21-gene recurrence score (RS)

Updated on:December 17,2023

Immunotherapy may become new first line treatment in some metastatic colorectal cancers

byEuropean Society for Medical OncologyCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Immunotherapy with nivolumab and low-dose ipilimumab could become a new fi

Updated on: December 18,2023

Immunotherapy may become new first line treatment in some metastatic colorectal cancers

byEuropean Society for Medical OncologyCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Immunotherapy with nivolumab and low-dose ipilimumab could become a new fi

Updated on:December 18,2023

Study shows early success of a novel drug in treating a rare and chronic blood cancer

by The Mount Sinai HospitalCredit: Pixabay/CC0 Public DomainA novel treatment for polycythemia vera, a potentially fatal blood cancer, demonstrated the ability to control overproduction of red bl

Updated on: May 21,2024

Study shows early success of a novel drug in treating a rare and chronic blood cancer

by The Mount Sinai HospitalCredit: Pixabay/CC0 Public DomainA novel treatment for polycythemia vera, a potentially fatal blood cancer, demonstrated the ability to control overproduction of red bl

Updated on:May 21,2024

Frailty score may predict outcomes in multiple myeloma

(HealthDay)—A frailty scale that includes Eastern Cooperative Oncology Group performance status (ECOG PS) may predict outcomes for transplant-ineligible patients with newly diagnosed multiple myeloma

Updated on: December 20,2023

Frailty score may predict outcomes in multiple myeloma

(HealthDay)—A frailty scale that includes Eastern Cooperative Oncology Group performance status (ECOG PS) may predict outcomes for transplant-ineligible patients with newly diagnosed multiple myeloma

Updated on:December 20,2023

Study reveals a new approach to enhancing response to immunotherapy in melanoma

bySanford Burnham Prebys Medical Discovery InstituteMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Scientists at

Updated on: December 20,2023

Study reveals a new approach to enhancing response to immunotherapy in melanoma

bySanford Burnham Prebys Medical Discovery InstituteMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Scientists at

Updated on:December 20,2023